Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
TTK Healthcare
|
Syncom Formulations
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.12 % | 21.89 % | 9.79 % |
|
5yr average Equity Multiplier
|
2.02 | 1.39 | 1.41 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.79 | 0.81 |
|
5yr Avg Net Profit Margin
|
13.41 % | 24.69 % | 8.78 % |
|
Price to Book
|
14.41 | 1.17 | 3.15 |
|
P/E
|
58.74 | 19.86 | 17.09 |
|
5yr Avg Cash Conversion Cycle
|
-114.74 Days | -18.91 Days | 61.57 Days |
|
Inventory Days
|
40.87 Days | 45.37 Days | 27.32 Days |
|
Days Receivable
|
186.38 Days | 39.11 Days | 82.75 Days |
|
Days Payable
|
342.97 Days | 124.35 Days | 79.41 Days |
|
5yr Average Interest Coverage Ratio
|
23.9 | 20.16 | 31.44 |
|
5yr Avg ROCE
|
14.63 % | 7.51 % | 13.63 % |
|
5yr Avg Operating Profit Margin
|
20.24 % | 4.27 % | 9.97 % |
|
5 yr average Debt to Equity
|
0.23 | 0.04 | 0.19 |
|
5yr CAGR Net Profit
|
119.04 % | 11.95 % | 36.24 % |
|
5yr Average Return on Assets
|
8.68 % | 16.71 % | 7.11 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 74.56 % | 50.57 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.06 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.98 % | 0.0 |
|
Shukra Pharma
|
TTK Healthcare
|
Syncom Formulations
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|